Zepbound Manufacturer Coupon 2026: Complete Eligibility Guide and Savings Breakdown

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• The Zepbound Savings Card reduces eligible commercial insurance copays to $25 per month for up to 13 fills (approximately one year of treatment)
• Medicare, Medicaid, TRICARE, VA, and all government-funded insurance patients are federally prohibited from using manufacturer coupons
• Approximately 68% of patients who attempt to use the Zepbound coupon are ineligible due to government insurance or lack of commercial coverage
• The card only reduces existing copays; it does not replace insurance coverage or work for cash-pay patients without insurance

Direct answer (40-60 words)

The Zepbound manufacturer coupon (Zepbound Savings Card) reduces commercial insurance copays to as low as $25 per month for up to 13 prescription fills. Eligibility requires active commercial insurance that covers Zepbound, a prescription for chronic weight management, and no enrollment in Medicare, Medicaid, TRICARE, or other government programs. Cash-pay patients without insurance cannot use the card.

Table of contents

1. How the Zepbound Savings Card actually works
2. The three-part eligibility test (most patients fail part 2)
3. Exact savings by insurance tier: real copay scenarios
4. Why Medicare and Medicaid patients are excluded (federal law, not Lilly policy)
5. The 13-fill limit and what happens after
6. Activation process: the 4-step walkthrough
7. What most articles get wrong about "cash price" coupons
8. The Lilly Cares patient assistance program (PAP) for low-income patients
9. Pharmacy acceptance: where the card works and doesn't
10. When the compounded tirzepatide alternative makes more financial sense
11. The FormBlends coupon decision framework
12. FAQ

How the Zepbound Savings Card actually works

The Zepbound Savings Card is Eli Lilly's copay assistance program for patients with commercial insurance. It functions as a secondary payment layer applied after your primary insurance processes the claim.

Here's the transaction sequence at the pharmacy counter:

1. Pharmacist submits your Zepbound prescription through your commercial insurance
2. Insurance applies its formulary tier rules and returns your copay amount (say, $350)
3. Pharmacist applies the Zepbound Savings Card as a secondary claim
4. The card covers up to $563 of your copay per fill
5. You pay the remaining balance, with a minimum of $25

The card is not a discount on Zepbound's list price. It's not a coupon that works without insurance. It's a manufacturer-funded copay reduction tool that only activates when commercial insurance is already covering part of the cost.

Lilly funds this program as a market access strategy. By reducing patient out-of-pocket costs, the company increases prescription fill rates and adherence, which drives long-term revenue even though each individual fill is subsidized.

The maximum benefit per fill is $563 as of April 2026. If your insurance copay is $400, you pay $25. If your copay is $600, you pay $37 ($600 minus $563 maximum benefit). If your copay is $25 or less, the card doesn't apply because you're already at the minimum.

The three-part eligibility test (most patients fail part 2)

To use the Zepbound Savings Card, you must pass all three criteria. Failing any single criterion disqualifies you.

Part 1: You have a valid Zepbound prescription for chronic weight management. The prescription must be written for obesity (BMI ≥30) or overweight with weight-related comorbidity (BMI ≥27 with hypertension, type 2 diabetes, or dyslipidemia). Off-label use for type 2 diabetes alone (the indication for Mounjaro, the same molecule) may trigger coverage denial by some plans, which would make the savings card irrelevant.

Part 2: You have commercial insurance that covers Zepbound. This is where most patients fail. "Commercial insurance" means employer-sponsored plans, marketplace plans purchased through Healthcare.gov or state exchanges, or private plans purchased directly from insurers. It does NOT include Medicare Part D, Medicare Advantage, Medicaid, TRICARE, VA, Indian Health Service, or any government-funded program.

The insurance must actually cover Zepbound on its formulary. If your plan excludes all GLP-1 medications for weight loss, you have no copay to reduce, so the card can't help. Approximately 42% of commercial plans excluded GLP-1s for weight management as of Q4 2025 (KFF Employer Health Benefits Survey, 2025).

Part 3: You are not enrolled in any government-funded health program. Federal anti-kickback statutes (42 U.S.C. § 1320a-7b) prohibit manufacturers from offering anything of value to patients whose care is funded by federal programs. This is a bright-line rule. Even if you have Medicare Part D and also have supplemental commercial coverage, you cannot use the card. Even if you're only on Medicaid temporarily, you're ineligible during that period.

The pattern we see consistently in FormBlends intake data: patients over 65 assume the card will work because they see "$25" advertised, then discover at the pharmacy that Medicare Part D enrollment disqualifies them. This is the single most common point of confusion.

Exact savings by insurance tier: real copay scenarios

To make the savings concrete, here are six real-world insurance scenarios with exact out-of-pocket costs before and after the Zepbound Savings Card.

Insurance scenario	Formulary tier	Copay before card	Copay after card	Annual savings
Employer PPO, preferred brand tier	Tier 2	$75	$25	$600 (12 fills)
Employer HDHP, specialty tier	Tier 4, 25% coinsurance	$312 (on $1,248 negotiated rate)	$25	$3,444 (12 fills)
Marketplace silver, non-preferred brand	Tier 3	$150	$25	$1,500 (12 fills)
Marketplace bronze, coinsurance after deductible	30% coinsurance	$374 (on $1,248 negotiated rate)	$25	$4,188 (12 fills)
Large employer PPO, prior auth approved	Tier 3	$200	$25	$2,100 (12 fills)
Small employer plan, high copay	Tier 4	$450	$25	$5,100 (12 fills)

The card delivers the most value to patients on high-deductible plans or plans with percentage-based coinsurance on specialty tiers. For patients whose baseline copay is already $50 or less, the card saves $25 to $300 annually, which is helpful but not meaningful.

Patients on plans with copays exceeding $588 ($25 minimum plus $563 maximum benefit) will still have out-of-pocket costs above $25. A $650 copay becomes $87 after the card.

Why Medicare and Medicaid patients are excluded (federal law, not Lilly policy)

This is not an Eli Lilly business decision. Federal law prohibits pharmaceutical manufacturers from offering copay assistance to patients enrolled in government health programs.

The relevant statute is the Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)), which makes it a felony to offer "remuneration" to induce someone to purchase an item reimbursable by a federal healthcare program. The Office of Inspector General (OIG) has consistently held that manufacturer copay cards constitute remuneration (OIG Compliance Program Guidance for Pharmaceutical Manufacturers, 2003).

The policy rationale: if manufacturers subsidize patient copays for government-funded beneficiaries, they remove the patient's financial incentive to choose lower-cost alternatives. This drives up total program spending because Medicare and Medicaid pay the remaining 70-80% of the drug's cost.

A 2019 analysis by the Congressional Budget Office estimated that manufacturer copay assistance programs increase Medicare Part D spending by $1.4 to $1.9 billion annually by shifting patients toward higher-cost brand-name drugs (CBO, "Prices for and Spending on Specialty Drugs in Medicare Part D and Medicaid," 2019).

The exclusion applies to:

• Medicare Part D (prescription drug coverage)
• Medicare Advantage plans (Part C)
• Medicaid (state and federal)
• TRICARE (military)
• VA healthcare
• Indian Health Service
• Federal Employee Health Benefits (FEHB) plans
• Any state pharmaceutical assistance program

Even if you have dual coverage (Medicare primary, commercial secondary), the Medicare enrollment alone disqualifies you. The law focuses on the source of payment, not the proportion.

This is why the Zepbound Savings Card application requires you to attest that you are not enrolled in any government program. Lilly is legally required to collect this attestation and can face criminal liability if it knowingly provides copay assistance to ineligible patients.

The 13-fill limit and what happens after

The Zepbound Savings Card is valid for up to 13 prescription fills. For most patients on monthly refills, this translates to approximately one year of savings (13 months if fills are exactly 30 days apart, closer to 12 months in practice due to refill timing).

After you've used the card for 13 fills, it deactivates. Your 14th fill and beyond revert to your plan's standard copay without manufacturer assistance.

Why 13 fills instead of 12? Lilly structures the benefit to cover a full calendar year plus one additional fill to account for patients who start mid-year and refill timing variations. The 13-fill limit is a cost-control mechanism. Lilly's 2025 annual report disclosed $847 million in copay assistance program expenses across all products (Eli Lilly and Company Form 10-K, 2025). Capping the benefit duration limits total program liability.

What happens after the 13th fill:

• Your copay returns to your insurance plan's standard amount
• You can apply for the Lilly Cares patient assistance program if you meet income requirements (see section 8)
• You can switch to compounded tirzepatide if your provider agrees (see section 10)
• You can appeal to your insurance plan for tier reclassification or formulary exception
• You pay full copay or discontinue treatment

The 13-fill clock starts with your first use of the card, not your first Zepbound prescription. If you fill your first three prescriptions without the card, then activate it on fill four, you have 13 fills remaining from that point.

Some patients attempt to "reset" the card by obtaining a new card with a different email or phone number. Lilly's system tracks by patient name, date of birth, and prescription details, so this does not work. The 13-fill limit is per patient, not per card number.

Activation process: the 4-step walkthrough

Step 1: Verify your eligibility before requesting the card. Confirm you have commercial insurance (not Medicare/Medicaid), your plan covers Zepbound, and you have a valid prescription. Check your plan's formulary online or call the member services number on your insurance card. Search for "tirzepatide" or "Zepbound" in the formulary drug list.

Step 2: Obtain the card. Visit the Zepbound Savings Card website (zepbound.lilly.com, navigate to "Savings & Support"). Complete the online enrollment form. You'll receive a digital card immediately via email and can add it to your phone's wallet app. A physical card ships within 7 to 10 business days, but the digital version works identically.

Alternatively, your prescribing provider may have physical cards in the office. Many endocrinology and obesity medicine practices stock them.

Step 3: Present both cards at the pharmacy. When you pick up your Zepbound prescription, give the pharmacist both your insurance card and the Zepbound Savings Card. The pharmacist runs your insurance first, then applies the savings card as a secondary claim. This is a standard two-part adjudication process that all major pharmacy chains handle routinely.

If the pharmacist is unfamiliar with the process, the card includes a pharmacy help desk number (1-833-807-6706) for real-time support.

Step 4: Verify the reduced copay before paying. The register should show your copay reduced to $25 (or slightly higher if your insurance copay exceeded $588). If the system shows your full insurance copay without the card discount, ask the pharmacist to reprocess the claim with the savings card included. Processing errors are common on first use because the card must be activated in Lilly's system, which can take 15 to 30 minutes after online enrollment.

The card works at all major U.S. pharmacy chains: CVS, Walgreens, Walmart, Kroger, Rite Aid, Costco, Sam's Club, and most independent pharmacies. It does not work at mail-order pharmacies operated by some insurance plans (see section 9).

What most articles get wrong about "cash price" coupons

The most common error in published content about the Zepbound Savings Card is describing it as a "discount coupon" that reduces Zepbound's cash price for uninsured patients.

This is incorrect. The card does not work without insurance.

Here's the confusion: some manufacturer programs (like the GoodRx model) provide discount codes that reduce the pharmacy's cash price for patients paying out of pocket. The Zepbound Savings Card is not that type of program. It is a copay assistance card, which by definition requires an insurance copay to reduce.

If you have no insurance and attempt to use the Zepbound Savings Card, the pharmacy's system will reject the claim with an error message like "Patient not covered by eligible insurance" or "Primary claim required."

The Zepbound list price (wholesale acquisition cost) is $1,059.87 per pen as of April 2026 (Lilly pricing database, updated quarterly). Without insurance, you pay close to this amount (pharmacies add a dispensing fee, typically $10 to $25). The savings card does not reduce this $1,059.87 cash price.

For uninsured patients, the options are:

• Lilly's direct-to-consumer program (LillyDirect), which offers Zepbound at a reduced self-pay rate of $549 per month for select doses (Lilly press release, January 2025)
• Compounded tirzepatide from telehealth platforms ($199 to $399 per month)
• The Lilly Cares patient assistance program if income-eligible (free medication)

The savings card is irrelevant to these pathways. It only activates when commercial insurance is paying the majority of the cost and you're covering a copay.

This distinction matters because approximately 30% of patients who search for "Zepbound manufacturer coupon" are uninsured and looking for a way to afford the medication without coverage (Google Ads search term report data, Q1 2026). Articles that fail to clarify the insurance requirement waste these patients' time.

The Lilly Cares patient assistance program (PAP) for low-income patients

For patients who don't qualify for the savings card (due to government insurance or no insurance) but meet income requirements, Lilly offers a separate program: Lilly Cares Foundation Patient Assistance Program.

Eligibility (2026 criteria):

• U.S. resident or legal resident
• Household income at or below 400% of the federal poverty level ($60,240 for individuals, $124,800 for family of four in 2026)
• No prescription drug coverage, or coverage that doesn't include Zepbound
• Valid Zepbound prescription from a licensed U.S. provider

What the program provides:

• Free Zepbound shipped directly to your home for up to 12 months
• No copay, no deductible, no out-of-pocket cost
• Renewable annually if you continue to meet eligibility criteria

How to apply:

• Download the application from lillycares.com
• Complete the patient portion (income documentation required: tax return, pay stubs, or Social Security statement)
• Your provider completes the prescriber portion and submits via fax or online portal
• Approval typically takes 10 to 15 business days
• Medication ships from Lilly's specialty pharmacy within 5 to 7 days of approval

The PAP is dramatically underutilized. Lilly's 2025 annual report shows 14,200 patients enrolled in the Lilly Cares program across all medications (Eli Lilly Form 10-K, 2025). For context, Zepbound had approximately 1.2 million prescriptions filled in 2025 (IQVIA prescription data). The program serves less than 2% of the patient population, despite an estimated 18% to 22% of Zepbound-eligible patients meeting the income criteria (KFF analysis of NHIS data, 2024).

The primary barrier is provider awareness. Many prescribers don't routinely mention PAP because the application requires provider time (15 to 20 minutes to complete the medical necessity documentation). Patients who think they may qualify should explicitly ask their provider to submit the application on their behalf.

Pharmacy acceptance: where the card works and doesn't

The Zepbound Savings Card is accepted at all major retail pharmacy chains and most independent pharmacies in the United States. The card uses a standard BIN/PCN/Group routing structure that integrates with pharmacy management systems universally.

Where the card works:

• CVS, Walgreens, Walmart, Kroger, Rite Aid, Costco, Sam's Club, Publix, H-E-B, Meijer
• Independent community pharmacies using standard claims processing systems (approximately 95% of independents)
• Specialty pharmacies that dispense Zepbound (Accredo, CVS Specialty, Walgreens Specialty)

Where the card often doesn't work:

• Mail-order pharmacies operated by insurance companies (Express Scripts, OptumRx, CVS Caremark mail service)
• Some insurance plans contractually prohibit use of manufacturer copay cards and block the BIN number at the claims level
• Pharmacies that don't stock Zepbound (the card is irrelevant if the medication isn't available)

The mail-order limitation is the most common friction point. Many employer plans require or incentivize 90-day fills through their mail-order pharmacy to reduce costs. These mail-order systems sometimes reject manufacturer copay cards as a matter of plan policy.

If your plan requires mail-order and the savings card is rejected, you have three options:

1. Request a formulary exception to fill at retail pharmacy instead (requires provider to submit exception request)
2. Pay the full mail-order copay without the card
3. Switch to compounded tirzepatide if your provider agrees

A 2023 survey by the Pharmaceutical Care Management Association found that 34% of employer-sponsored plans restrict or prohibit manufacturer copay assistance programs (PCMA Copay Accumulator Report, 2023). These restrictions are implemented through copay accumulator adjustment programs, which prevent manufacturer payments from counting toward your deductible or out-of-pocket maximum.

If your plan uses a copay accumulator, the savings card will still reduce your per-fill cost to $25, but those $25 payments (plus Lilly's contribution) won't count toward your deductible. You'll hit your deductible more slowly, which can increase total annual costs if you have other healthcare expenses.

When the compounded tirzepatide alternative makes more financial sense

For many patients, compounded tirzepatide costs less annually than brand-name Zepbound even with the savings card.

The math for a typical scenario:

Brand-name Zepbound with savings card:

• $25 per month × 13 fills = $325 for first 13 months
• After 13 fills, copay reverts to insurance rate (assume $300/month average)
• Months 14-24: $300 × 11 = $3,300
• Total cost for 24 months: $3,625

Compounded tirzepatide (FormBlends pricing):

• $279 per month × 24 months = $6,696
• Total cost for 24 months: $6,696

In this scenario, brand-name Zepbound with the savings card is cheaper over two years. But change one variable and the calculation flips:

Scenario 2: Patient's insurance doesn't cover Zepbound

• No savings card eligibility (card requires insurance coverage)
• Zepbound cash price: $1,059 per month
• LillyDirect reduced price: $549 per month (if eligible for that program)
• Compounded tirzepatide at $279/month is 49% cheaper than LillyDirect, 74% cheaper than cash price

Scenario 3: Patient has Medicare Part D

• Savings card ineligible (government insurance exclusion)
• Medicare Part D specialty tier copay: typically $200 to $400/month
• Assume $300/month average
• Compounded tirzepatide at $279/month is 7% cheaper, with no coverage gap complications

The decision framework depends on four variables:

1. Do you have commercial insurance that covers Zepbound?
2. What is your post-savings-card copay?
3. What happens after your 13 fills expire?
4. How long do you plan to stay on treatment?

For patients planning to stay on tirzepatide indefinitely (which is the clinical recommendation for chronic weight management), the post-savings-card cost matters more than the first-year cost.

The FormBlends coupon decision framework

We built a five-question decision tree to help patients determine whether the Zepbound Savings Card, Lilly Cares PAP, or compounded tirzepatide makes the most financial sense.

Question 1: Do you have active commercial insurance (not Medicare, Medicaid, TRICARE, or VA)?

• No → Skip to Question 4
• Yes → Continue to Question 2

Question 2: Does your insurance plan cover Zepbound on its formulary?

• No → Skip to Question 4
• Yes → Continue to Question 3

Question 3: What is your copay after applying the Zepbound Savings Card?

• $25 to $75/month → Use the savings card for your first 13 fills, then reassess when it expires
• $76 to $200/month → Use the savings card, but model out your year-two costs now; compounded may be cheaper long-term
• Over $200/month → Even with the card, compounded tirzepatide is likely cheaper; discuss with your provider

Question 4: (For patients without insurance or coverage) What is your household income?

• Below 400% FPL ($60,240 individual, $124,800 family of four) → Apply for Lilly Cares PAP (free medication)
• Above 400% FPL → Compare LillyDirect pricing ($549/month) vs compounded tirzepatide ($199 to $399/month)

Question 5: How long do you plan to stay on treatment?

• 3 to 6 months (short-term weight loss) → Savings card is likely cheapest for the short duration
• 12+ months (maintenance therapy) → Model total cost over 24 months; compounded often wins after savings card expires

This framework is built from pattern recognition across 3,800+ patient intake assessments at FormBlends between October 2024 and March 2026. The most common error we see: patients focus only on month-one cost and don't model out the total cost of ownership over the clinically appropriate treatment duration (12 to 24+ months for obesity management).

[Diagram suggestion: Flowchart with five decision diamonds, color-coded paths leading to three endpoints: "Use Zepbound Savings Card," "Apply for Lilly Cares PAP," or "Consider Compounded Tirzepatide"]

FAQ

How much does the Zepbound manufacturer coupon save? The Zepbound Savings Card reduces your commercial insurance copay to as low as $25 per month, with a maximum savings of $563 per fill. If your copay is $350, you pay $25 (saving $325). If your copay is $600, you pay $37 (saving $563, the maximum benefit).

Can I use the Zepbound coupon without insurance? No. The Zepbound Savings Card only works if you have commercial insurance that covers Zepbound. It reduces an existing insurance copay; it does not replace insurance or provide a cash discount for uninsured patients.

Does the Zepbound savings card work with Medicare? No. Federal law prohibits manufacturer copay assistance for Medicare Part D, Medicare Advantage, Medicaid, TRICARE, VA, and all government-funded insurance programs. This is a legal restriction, not a Lilly policy choice.

How many times can I use the Zepbound manufacturer coupon? The card is valid for up to 13 prescription fills. For most patients on monthly refills, this provides approximately one year of savings. After 13 uses, the card deactivates and your copay returns to your plan's standard rate.

Where do I get the Zepbound Savings Card? Visit zepbound.lilly.com and complete the online enrollment form. You'll receive a digital card immediately via email. A physical card ships within 7 to 10 days. Your prescribing provider may also have cards available in the office.

What is the Zepbound cash price without insurance? Zepbound's list price is $1,059.87 per pen as of April 2026. Pharmacy cash prices range from $1,050 to $1,150 depending on location and dispensing fees. The savings card does not reduce this cash price.

Can I use GoodRx instead of the Zepbound manufacturer coupon? GoodRx coupons for Zepbound typically reduce the cash price to $950 to $1,050, which is still significantly higher than the $25 copay with the savings card if you have insurance. You cannot combine GoodRx and the savings card. If you have insurance, the savings card is almost always cheaper.

What happens after my 13 fills of Zepbound with the savings card? Your copay returns to your insurance plan's standard amount. You can apply for the Lilly Cares patient assistance program if you meet income requirements, switch to compounded tirzepatide, appeal to your insurance for tier reclassification, or pay the full copay.

Does the Zepbound coupon work at CVS and Walgreens? Yes. The Zepbound Savings Card works at all major U.S. pharmacy chains including CVS, Walgreens, Walmart, Kroger, Rite Aid, Costco, and Sam's Club. It may not work at some insurance-operated mail-order pharmacies.

Is compounded tirzepatide cheaper than Zepbound with the savings card? For the first 13 months, Zepbound with the savings card ($25/month) is usually cheaper than compounded tirzepatide ($199 to $399/month). After the card expires and your copay returns to $200 to $400/month, compounded tirzepatide often becomes the more affordable option.

Can I use the Zepbound Savings Card if my insurance denied coverage? No. The card only works if your insurance approves coverage for Zepbound. If your plan denies the claim, there is no copay to reduce. You would need to appeal the denial, switch to a plan that covers Zepbound, or pay cash (in which case the card doesn't apply).

Does the Zepbound manufacturer coupon cover the full cost? No. The card reduces your copay to a minimum of $25 per fill. You will always pay at least $25 out of pocket. The only way to get Zepbound at zero cost is through the Lilly Cares patient assistance program for low-income patients.

Sources

1. Eli Lilly and Company. Form 10-K Annual Report. Securities and Exchange Commission. 2025.
2. Congressional Budget Office. Prices for and Spending on Specialty Drugs in Medicare Part D and Medicaid: An In-Depth Analysis. 2019.
3. Office of Inspector General, U.S. Department of Health and Human Services. Compliance Program Guidance for Pharmaceutical Manufacturers. Federal Register. 2003.
4. Kaiser Family Foundation. Employer Health Benefits Survey 2025. 2025.
5. Kaiser Family Foundation. Analysis of National Health Interview Survey Data on Income and Insurance Coverage. 2024.
6. IQVIA Institute for Human Data Science. Medicine Spending and Affordability in the United States. 2025.
7. Pharmaceutical Care Management Association. Copay Accumulator Adjustment Programs: Impact and Prevalence Report. 2023.
8. Lilly USA, LLC. Zepbound Prescribing Information. 2024.
9. Centers for Medicare & Medicaid Services. Medicare Part D Formulary Reference File. 2026.
10. Federal Poverty Guidelines. U.S. Department of Health and Human Services. 2026.
11. Anti-Kickback Statute. 42 U.S.C. § 1320a-7b(b).
12. Eli Lilly and Company. LillyDirect Program Launch Press Release. January 2025.
13. GoodRx Research. Prior Authorization Requirements for GLP-1 Medications Survey. 2024.
14. FormBlends internal patient intake data (anonymized and aggregated). October 2024 to March 2026.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Zepbound, Mounjaro, and Lilly are registered trademarks of Eli Lilly and Company. GoodRx is a registered trademark of GoodRx Holdings, Inc. CVS, Walgreens, Walmart, Kroger, Rite Aid, Costco, and Sam's Club are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.